Forced expression of the TNF-family gene in lung cancer cells produced therapeutic effects, stimulating antigen-presentation processes.
肺癌细胞中 TNF 家族基因的强制表达产生了治疗效果,刺激了抗原呈递过程。
基本信息
- 批准号:12671337
- 负责人:
- 金额:$ 2.18万
- 依托单位:
- 依托单位国家:日本
- 项目类别:Grant-in-Aid for Scientific Research (C)
- 财政年份:2000
- 资助国家:日本
- 起止时间:2000 至 2001
- 项目状态:已结题
- 来源:
- 关键词:
项目摘要
Induction of cytotoxic T cells, responsible for cell-mediated immunity, requires the activation of dendritic cells (DC) which play a crucial role in antigen-presentation. We examined in this study whether activation of DC could be performed by gene transfer of the TNF-family gene and consequently antitumor effects were produced against lung cancer cells. Murine lung carcinoma Lewis cells were transfected with the TNF-family gene and established clones were subcutaneously inoculated into syngeneic mice. The growth of CD40 ligand-expressed tumors was significantly retarded compared with that of parent tumors and the number of spontaneous lung metastatic foci was significantly reduced. The immunocompetent mice that were inoculated with the Fas ligand-expressed tumors did not developed tumors and the mice generated tumor-specific protective immunity. The mice did not produce any lung metastatic foci. The growth of the TNF-α-expressed tumors was not different from that of parent tumors but the number of metastatic foci was significantly decreased. In order to analyze the involvement of DC in this antitumor effects, we cocultured DC that were obtained from bone-marrow cells with the transfected cells. DC formed cluster with Fas ligand-expressed but not parent tumors. The expression of CD86, an activation marker an costimulatory molecule of DC, was upregulated during the coculture with CD40 ligand-expressed tumors. Fas ligand and CD40 ligand seem to be involved in antigen processing and maturation of DC, respectively.
负责细胞介导免疫的细胞毒性T细胞的诱导需要在抗原呈递中起关键作用的树突状细胞(DC)的活化。在这项研究中,我们研究了是否可以通过转移TNF家族基因来激活DC,从而对肺癌细胞产生抗肿瘤作用。小鼠肺癌刘易斯细胞转染TNF家族基因,并建立克隆皮下接种到同基因小鼠。表达CD 40配体的肿瘤的生长与母瘤相比显著减慢,自发性肺转移灶的数量显著减少。接种Fas配体表达的肿瘤的免疫活性小鼠没有发生肿瘤,并且小鼠产生了肿瘤特异性保护性免疫。小鼠未产生任何肺转移灶。TNF-α表达的肿瘤的生长与母瘤的生长无差异,但转移灶的数量显著减少。为了分析DC在这种抗肿瘤作用中的参与,我们将从骨髓细胞中获得的DC与转染细胞共培养。DC与表达Fas配体的肿瘤成簇,但与母瘤不成簇。在与表达CD 40配体的肿瘤共培养期间,DC的活化标记物、共刺激分子CD 86的表达上调。Fas配体和CD 40配体可能分别参与DC的抗原加工和成熟。
项目成果
期刊论文数量(34)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
Iwadate, Y., Yamaura, A., Sato, Y., Sakiyama, S. and Tagawa. M.: "Induction of immunity in peripheral tissues combined with intracerebral transplantation of interleukin 2-producing cells eliminates established brain tumors"Cancer Res. 61. 8769-8774 (2001)
岩馆,Y.,山浦,A.,佐藤,Y.,崎山,S.和田川。
- DOI:
- 发表时间:
- 期刊:
- 影响因子:0
- 作者:
- 通讯作者:
Tada, Y., O-Wang, J., Takiguchi, Y., Tatsumi, K., Kuriyama, T. and Tagawa, M.: "T cell dependent and independent antitumor immunity generated by the expression of Fas ligand on mouse lung carcinoma cells"Int. J. Mol. Med. (in press).
Tada, Y.、O-Wang, J.、Takiguchi, Y.、Tatsumi, K.、Kuriyama, T. 和 Takawa, M.:“小鼠肺上 Fas 配体表达产生的 T 细胞依赖性和非依赖性抗肿瘤免疫
- DOI:
- 发表时间:
- 期刊:
- 影响因子:0
- 作者:
- 通讯作者:
Namba,H.,Tagawa,M. et al: "Treatment of rat experimental brain tumor by herpes simplex virus thymidine kinase gene-transduced allogeneic tumor cells and ganciclovir."Cancer Gene Ther. 7. 947-953 (2000)
难波,H.,田川,M.
- DOI:
- 发表时间:
- 期刊:
- 影响因子:0
- 作者:
- 通讯作者:
Narita M, Tagawa M, et al.: "Tissite-specific expression of a suicide gene for selective killing of rieuroblastoma cells using a promoter region of the NCX gene"Cancer Gene Ther.. 8. 997-1002 (2001)
Narita M,Takawa M,等人:“使用NCX基因的启动子区域选择性杀死神经母细胞瘤细胞的自杀基因的Tissite-specific表达”Cancer Gene Ther.. 8. 997-1002 (2001)
- DOI:
- 发表时间:
- 期刊:
- 影响因子:0
- 作者:
- 通讯作者:
Tada, Y., O-Wang, J., Seimiya, M., Takiguchi, Y., Tatsumi, K., Kuriyama, T. and Tagawa. M.: "Antitumor effects are produced by forced expression of membrane-bound but not soluble Fas ligand in murine lung carcinoma cells"Anticancer Res. (in press).
Tada, Y.、O-Wang, J.、Seimiya, M.、Takiguchi, Y.、Tatsumi, K.、Kuriyama, T. 和 Takawa。
- DOI:
- 发表时间:
- 期刊:
- 影响因子:0
- 作者:
- 通讯作者:
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
KOSHIKAWA Nobuko其他文献
KOSHIKAWA Nobuko的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('KOSHIKAWA Nobuko', 18)}}的其他基金
Comparison of the frequency of mtDNA mutation in primary and metastatic lesions of human malignant tumors
人类恶性肿瘤原发灶和转移灶mtDNA突变频率比较
- 批准号:
21590349 - 财政年份:2009
- 资助金额:
$ 2.18万 - 项目类别:
Grant-in-Aid for Scientific Research (C)
Effect of HIF inhibitors on tumor hypoxia-induced dedifferentiation and metastasis of lung carcinoma cells
HIF抑制剂对肿瘤缺氧诱导的肺癌细胞去分化和转移的影响
- 批准号:
19591655 - 财政年份:2007
- 资助金额:
$ 2.18万 - 项目类别:
Grant-in-Aid for Scientific Research (C)
Cell-cidal effect of the combination therapy of p53 gene under the control of radiation- and hypoxia-sensitized promoter and heavy particle irradiation in glioma
放疗缺氧增敏启动子控制下的p53基因与重粒子线照射联合治疗胶质瘤细胞杀伤作用
- 批准号:
16591466 - 财政年份:2004
- 资助金额:
$ 2.18万 - 项目类别:
Grant-in-Aid for Scientific Research (C)
相似国自然基金
CD40 ligand 转基因B淋巴瘤细胞来源exosome的抗肿瘤作用
- 批准号:81071948
- 批准年份:2010
- 资助金额:10.0 万元
- 项目类别:面上项目
相似海外基金
Development of innovative treatment targeted for CD40 ligand for patients with multiple sclerosis
开发针对多发性硬化症患者的 CD40 配体创新疗法
- 批准号:
17K16109 - 财政年份:2017
- 资助金额:
$ 2.18万 - 项目类别:
Grant-in-Aid for Young Scientists (B)
The Effects of CD40 Ligand Deficiency on Vascular Dysfunction, Immunoglobulin Production and Lymph Capillary Density in a Murine Model for High-Salt Diet
CD40 配体缺陷对高盐饮食小鼠模型中血管功能障碍、免疫球蛋白产生和毛细淋巴管密度的影响
- 批准号:
290587856 - 财政年份:2015
- 资助金额:
$ 2.18万 - 项目类别:
Research Fellowships
Ovarian cancer therapy using CD40 Ligand (CD40L)
使用 CD40 配体 (CD40L) 治疗卵巢癌
- 批准号:
8648384 - 财政年份:2014
- 资助金额:
$ 2.18万 - 项目类别:
Development of a multimeric CD40 ligand vaccine adjuvant
多聚体CD40配体疫苗佐剂的开发
- 批准号:
8456940 - 财政年份:2013
- 资助金额:
$ 2.18万 - 项目类别:
Development of a multimeric CD40 ligand vaccine adjuvant
多聚体CD40配体疫苗佐剂的开发
- 批准号:
8715683 - 财政年份:2013
- 资助金额:
$ 2.18万 - 项目类别:
Deciphering the role of CD40/CD40 ligand interaction in germinal center development using multiphoton intravital microscopy
使用多光子活体显微镜解读 CD40/CD40 配体相互作用在生发中心发育中的作用
- 批准号:
269571 - 财政年份:2012
- 资助金额:
$ 2.18万 - 项目类别:
Fellowship Programs
CD40 LIGAND AS ADJUVANT FOR RAISING PROTECTIVE ANTI-HIV AB BY DNA/MVA VACCINES
CD40 配体作为 DNA/MVA 疫苗产生保护性抗 HIV AB 的佐剂
- 批准号:
7715809 - 财政年份:2008
- 资助金额:
$ 2.18万 - 项目类别:
Establishment of diagnostic method of causative drug by detection of CD40 ligand expression in acute stage of drug eruption
药疹急性期CD40配体表达检测药物诊断方法的建立
- 批准号:
19790776 - 财政年份:2007
- 资助金额:
$ 2.18万 - 项目类别:
Grant-in-Aid for Young Scientists (B)
CD40 LIGAND AS ADJUVANT FOR RAISING PROTECTIVE ANTI-HIV AB BY DNA/MVA VACCINES
CD40 配体作为 DNA/MVA 疫苗产生保护性抗 HIV AB 的佐剂
- 批准号:
7562678 - 财政年份:2007
- 资助金额:
$ 2.18万 - 项目类别:
Immunotherapy of CLL with lentiviral expressed CD40-ligand
使用慢病毒表达的 CD40 配体进行 CLL 免疫治疗
- 批准号:
7161658 - 财政年份:2006
- 资助金额:
$ 2.18万 - 项目类别: